> Download programme as PDF (50 kb)
> go to Friday 11 April 2008 (day 2)

08:30 - 09:00	Registration, coffee and pastries
09:00 - 10:00	Opening and keynote address
	Welcoming remarks Prof Mark Pieth President, Basel Institute on Governance
	Dr Pascoal Mocumbi Haut Représentant, European and Developing Countries Clinical Trials Partnership (EDCTP), former Prime Minister of Mozambique
	Prof Helmut K Anheier Professor of Sociology at Heidelberg University, Germany; Director of the Center for Civil Society, University of California
10:00 - 10:30	Coffee break
10:30 - 12:15	The changing paradigms of global health
	Prof Marcel Tanner (Chair) Director, Swiss Tropical Institute
	"Avoiding pouring money down the rathole" Donald G. McNeil Jr. Science Journalist, The New York Times
	"Changing Perspectives on Global Health Philanthropy: Governance Challenges" Dr Guy Pfeffermann CEO and Chairman of the Board of the Management Education & Research Consortium, and former Director of the Global Business School Network of the International Finance Corporation
	"Why and how does the private sector invest in global health ?" Andreas Holzer Sustainability Research, Bank Sarasin
12:15 - 13:15	Buffet Lunch/Networking
13:15 - 14:45	Effectiveness of philanthropy (case studies)
	Dr Kazem Behbehani (Chair) Former WHO Assistant Director General
	"Business as a partner – engaging models of the Global Fund" David Hayward Evans Corporate Partnerships Manager, the Global Fund
	"Business comes on board" Dr Robin Donnelly Vice President Shell Health, Royal Dutch/Shell Group
	"Foundations as catalysts for health-related projects" Dr Stephen Robinson General Manager, Novo Nordisk Haemophilia Foundation
14:45 - 15:00	Coffee break
15:00 - 17:00	Governance and Effectiveness challenges (two parallel workshops)
	Workshop 1: Transparency, legitimacy and accountability of private initiatives
	Prof Anne Peters (Chair) Vice-President, Basel Institute on Governance
	Dr Malebona Matsoso (keynote speaker) Director Public Health Innovation and Intellectual Property, Office of the Director General, WHO
	Silvio Gabriel Executive Vice President, Head of Malaria Initiatives, Novartis Pharma AG
	Dr Kaspar Wyss Project Leader, Swiss Tropical Institute
	Workshop 2: Governance of R & D for neglected diseases
	Prof Anton K. Schnyder (Chair) Member of the Board, Basel Institute on Governance
	Dr Chris Hentschel (keynote speaker) President and Chief Executive Officer, Medicines for Malaria Venture (MMV)
	Prof Marcel Tanner Chairman of the Board of DNDi (Drugs for Neglected Diseases initiative)
	Dr Klaus Rose Head Pediatrics, Hoffmann-La Roche
19:00	Conference dinner/Networking

08:30 - 09:00	Coffee and pastries
09:00 - 09:30	Workshop reports to the plenary
	Gretta Fenner (Chair) Director, Basel Institute on Governance
	Rapporteurs of workshops
09:30 - 11:00	The way forward – Examples of self-governance
	Dr Hans-Peter Bauer (Chair) Member of the Board, Basel Institute on Governance
	"The Global Fund as an example of self-governance in the public health sector" Enrico Mollica Director Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria, Geneva
	"Orientation in self-governing systems - a heuristic approach" Vincent Paul Menken Executive Assistant to the Management Board, Bertelsmann Stiftung
	"Assuring humanitarian accountability and quality " Radha Dawn Ivory Basel Institute on Governance, speaking on behalf of the Humanitarian Accountability Partnership-International (HAP-I)
11:00 - 11:15	Coffee and pastries
11:15 - 12:15	The way forward (cont’d) – Panel discussion
	Prof Mark Pieth (Chair) President, Basel Institute on Governance
	Dr Kazem Behbehani Former WHO Assistant Director General
	Donald G. McNeil Jr. Science Journalist, The New York Times
	Dr Pascoal Mocumbi Haut Représentant, European and Developing Countries Clinical Trials Partnership (EDCTP), former Prime Minister of Mozambique
	Prof Marcel Tanner Director, Swiss Tropical Institute
12:15 - 12:30	Chairman’s summary and conclusions
	Prof Mark Pieth President, Basel Institute on Governance